Biopharmaceutical research companies are conducting or have conducted more than 7,800 clinical trials of new medicines in collaboration with the state’s university medical schools, clinical research centers, and hospitals (1999 to present).

Of the more than 7,800 clinical trials, 3,840 target the nation’s six most debilitating chronic diseases —asthma, cancer, diabetes, heart disease, mental illnesses and stroke.